| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.8M | -71.9% |
| R&D Expense | $21.5M | -28.3% |
| SG&A Expense | $12.1M | +7.7% |
| Operating Income | -$30.9M | +1.4% |
| Pre-tax Income | -$30.2M | +2.5% |
| Income Tax | $0 | — |
| Net Income | -$30.2M | +2.5% |
| EPS (Basic) | -$0.35 | +5.4% |
| EPS (Diluted) | -$0.35 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.5M | -69.8% |
| Current Assets | $17.5M | -59.2% |
| Total Assets | $21.3M | -51.4% |
| Current Liabilities | $20.5M | -35.2% |
| Total Liabilities | $26.3M | -19.5% |
| Stockholders' Equity | -$5.0M | -145.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.9M | -114.8% |
| Capital Expenditures | $629K | +898.0% |
| Investing Cash Flow | -$629K | -898.0% |
| Financing Cash Flow | $15.6M | +1064.0% |
| Free Cash Flow | -$39.5M | -117.5% |
| +5.4% |